“Social media is ubiquitous today, and it has dramatically changed how we practice medicine, how we learn, and how we disseminate information,” said Christopher Carroll, MD, FCCP.

Angel O. Coz Yataco, MD, FCCP, will help discuss the pros and cons of the latest iteration of the Surviving Sepsis Campaign (SSC) Guidelines, which were published in 2021.

The CHEST Foundation is offering a host of opportunities for attendees at CHEST 2022 to reconnect with peers, support initiatives designed to improve the lives of patients with pulmonary diseases, and have a lot of fun.

These sessions focusing on various issues relevant to a specific clinical area or topic are a great way to expand your knowledge and improve your understanding of specialized tracks. Many Spotlight Session tracks also offer a certificate of completion to show your mastery in the topic.

Visit the Guidelines Pod at Experience CHEST, Booth 2026, to learn how clinicians at every career level can support the practice of medicine globally, make a difference in improving patient care, and enhance their own clinical expertise by contributing to a CHEST guideline.

Three years into the pandemic, lessons from COVID-19 are coming into focus. So are gaps in reporting, data collection, and actionable information.

Every aspect of the 2-hour event will emphasize renewed joy and connection, starting with the welcome from Scientific Program Committee Chair, Subani Chandra, MD, FCCP, all the way through to a highly anticipated keynote address.

Bhavinkumar D. Dalal, MD, FCCP, will join other pulmonary and critical care medicine (PCCM) program directors in discussing key changes and challenges in implementing the new Milestones framework.

Lauren Tobias, MD, will lead a panel of sleep health specialists in discussing novel interventions to address disparities as well as strategies for recruiting a diverse sleep medicine workforce.

Roxana Sulica, MD, will chair a discussion of PH due to left heart disease, including management strategies, clinical presentation, and approaches to distinguishing Group II from Group I PH.